Wnt activated tumors exhibit aberrant IGF signaling that promotes proliferation and tumor growth, while inhibition of Wnt signaling with a soluble frizzled8 fusion protein that competes for Wnt1 binding caused activation of IGFBP5, downregulation of IGF signaling, and tumor regression (103). The gene discussed is IGFBP5; the disease is neoplasm.